South and Central America In-Vitro Diagnostics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product and Services (Reagents and Kits, Instruments, and Software and Services); Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others); Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others); End User (Hospitals, Laboratories, Homecare, and Others)

Publication Month: May 2021 | Report Code: TIPRE00022126 | No. of Pages: 195 | Category: Medical Device | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The In-vitro diagnostics market in South and Central America is expected to grow from US$ 4,387.7 million in 2019 to US$ 5,820.0 million by 2027; it is estimated to grow at a CAGR of 3.6% from 2020 to 2027.

The region is witnessing exponential increase in prevalence of infectious diseases. These diseases are prominently caused due to pathogenic microorganisms, such as viruses, bacteria, and parasites. Certain factors, such as poor sanitary conditions, lack of public hygiene, massive air pollution, and lack of safe drinking water, are playing a significant role in the increasing prevalence of infectious diseases. For instance, according to data published by the World Health Organization (WHO) in 2019, approximately 71.0 million people suffered from hepatitis C virus infection across the globe. Moreover, extreme globalization, intense mobility of the population, and persistent urbanization are expected to spread viral infections with greater ease. Since there is a lack of better public health surveillance systems and access to care, a substantial population in developing countries as well as remote regions, is highly prone to viral infections. This, combined with considerable growth in the viral epidemics, is projected to offer a high demand the in-vitro diagnostics (IVD) during the forecast period.

 

In the South and Central American region, countries like Brazil, Chile, and Peru have experienced significant incidences of COVID-19 patients. According to the Pan American Health Organization (PAHO), as of 12 June 2020, Brazil, Peru, and Chile had 5.1%, 2.8%, and 1.8% crude case fatality rates (CFR). Maximum deaths were observed in the age group 60 to 70+ years old. In addition. 60% of these deaths in this age group occurred in men. Therefore, considering the rise in the incidences have demanded IVD test kits and products. The biotechnology industry is growing in the countries that are expected to serve vital growth opportunities for the IVD market in the coming future.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the In-vitro diagnostics market. The South and Central America In-vitro diagnostics market is expected to grow at a good CAGR during the forecast period.


Get more information on this report :

South and Central America In-Vitro Diagnostics Market Segmentation          

By Product and Services

  • Instruments
  • Reagents & Kits
  • Software & Services

By Technology

  • Immunoassay/ Immunochemistry
  • Clinical Chemistry
  • Molecular Diagnostics
  • Microbiology
  • Blood Glucose Self-Monitoring
  • Coagulation & Hemostasis
  • Hematology
  • Urinalysis
  • Others

By Application

  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Autoimmune Diseases
  • Nephrology
  • Others

By End User

  • Hospitals
  • Laboratories
  • Homecare
  • Others

By Country

  • South and Central America
    • Brazil
    • Argentina
    • Rest of South and Central America

Companies Mentioned

  • F. HOFFMANN-LA ROCHE LTD.
  • DANAHER
  • ABBOTT
  • SIEMENS AG
  • SYSMEX CORPORATION
  • THERMO FISHER SCIENTIFIC, INC.
  • BD
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES, INC.
  • QIAGEN

 

1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          In-Vitro Diagnostics Market – By Product and Services

1.3.2          In-Vitro Diagnostics Market – By Technology

1.3.3          In-Vitro Diagnostics Market – By Application

1.3.4          In-Vitro Diagnostics Market – By End User

1.3.5          South and Central America In-Vitro Diagnostics Market – By Country

2.           South and Central America In-Vitro Diagnostics Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           South and Central America In-Vitro Diagnostics Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          In-Vitro Diagnostics Market- South and Central America PEST Analysis

4.3          Expert Opinion

5.           South and Central America In-Vitro Diagnostics Market - Key Market Dynamics

5.1          Market Drivers

5.1.1          Increasing Prevalence of Chronic and Infectious Diseases

5.1.2          Growing Geriatric Population

5.1.3          Rising Demand for In-Vitro Diagnostics During COVID-19 Pandemic

5.2          Market Restraints

5.2.1          Lack of Healthcare Infrastructure and Reimbursement Policies

5.3          Future Trends

5.3.1          Increasing Adoption and Popularity of Automation in Clinical Laboratories

5.4          Impact Analysis

6.           In-Vitro Diagnostics Market – South and Central America Analysis

6.1          South and Central America In-Vitro Diagnostics Market Revenue Forecasts and Analysis

7.           South and Central America In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Product and Services

7.1          Overview

7.2          In-Vitro Diagnostics, by Product and Services, 2019 & 2027 (% Share)

7.3          Reagents & Kits

7.3.1          Overview

7.3.2          Reagents & Kits Market Revenue and Forecast to 2027 (US$ Mn)

7.4          Instruments

7.4.1          Overview

7.4.2          Instruments Market Revenue and Forecast to 2027 (US$ Mn)

7.5          Software & Services

7.5.1          Overview

7.5.2          Software & Services Market Revenue and Forecast to 2027 (US$ Mn)

8.           South and Central America In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Technology

8.1          Overview

8.2          In-Vitro Diagnostics Market, by Technology, 2019 & 2027 (% Share)

8.3          Immunoassay/Immunochemistry

8.3.1          Overview

8.3.2          Immunoassay/Immunochemistry Market Revenue and Forecast to 2027 (US$ Mn)

8.4          Clinical Chemistry

8.4.1          Overview

8.4.2          Clinical Chemistry Market Revenue and Forecast to 2027 (US$ Mn)

8.5          Molecular Diagnostics

8.5.1          Overview

8.5.2          Molecular Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

8.6          Microbiology

8.6.1          Overview

8.6.2          Microbiology Market Revenue and Forecast to 2027 (US$ Mn)

8.7          Blood Glucose Self-Monitoring

8.7.1          Overview

8.7.2          Blood Glucose Self-Monitoring Market Revenue and Forecast to 2027 (US$ Mn)

8.8          Coagulation and Hemostasis

8.8.1          Overview

8.8.2          Coagulation and Hemostasis Market Revenue and Forecast to 2027 (US$ Mn)

8.9          Haematology

8.9.1          Overview

8.9.2          Haematology Market Revenue and Forecast to 2027 (US$ Mn)

8.10        Urinalysis

8.10.1        Overview

8.10.2        Urinalysis Market Revenue and Forecast to 2027 (US$ Mn)

8.11        Others

8.11.1        Overview

8.11.2        Others Market Revenue and Forecast to 2027 (US$ Mn)

9.           South and Central America In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Application

9.1          Overview

9.2          In-Vitro Diagnostics Market, by Application, 2019 & 2027 (% Share)

9.3          Infectious Diseases

9.3.1          Overview

9.3.2          Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)

9.4          Diabetes

9.4.1          Overview

9.4.2          Diabetes Market Revenue and Forecast to 2027 (US$ Mn)

9.5          Oncology

9.5.1          Overview

9.5.2          Oncology Market Revenue and Forecast to 2027 (US$ Mn)

9.6          Cardiology

9.6.1          Overview

9.6.2          Cardiology Market Revenue and Forecast to 2027 (US$ Mn)

9.7          Autoimmune Disease

9.7.1          Overview

9.7.2          Autoimmune Disease Market Revenue and Forecast to 2027 (US$ Mn)

9.8          Nephrology

9.8.1          Overview

9.8.2          Nephrology Market Revenue and Forecast to 2027 (US$ Mn)

9.9          Others

9.9.1          Overview

9.9.2          Others Market Revenue and Forecast to 2027 (US$ Mn)

10.        South and Central America In-Vitro Diagnostics Market Analysis and Forecasts to 2027– By End user

10.1        Overview

10.2        In-Vitro Diagnostics Market Share by End User 2019 & 2027 (%)

10.3        Hospitals

10.3.1        Overview

10.3.2        Hospitals Market Revenue and Forecast to 2027 (US$ Mn)

10.4        Laboratories

10.4.1        Overview

10.4.2        Laboratories Market Revenue and Forecast to 2027 (US$ Mn)

10.5        Homecare

10.5.1        Overview

10.5.2        Homecare Market Revenue and Forecast to 2027 (US$ Mn)

10.6        Others

10.6.1        Overview

10.6.2        Others Market Revenue and Forecast to 2027 (US$ Mn)

11.        In-Vitro Diagnostics Market Revenue and Forecasts to 2027 – Geographical Analysis

11.1        South and Central America In-Vitro Diagnostics Market Revenue And Forecast To 2027

11.1.1        South and Central America In-Vitro Diagnostics Market Revenue and Forecast to 2027, By Country (%)

11.1.2        Brazil

11.1.2.1          Brazil In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.2.1.1           Brazil In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product and Services (US$ Mn)

11.1.2.1.2           Brazil In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.2.1.3           Brazil In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.2.1.4           Brazil In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

11.1.3        Argentina

11.1.3.1          Argentina In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.3.1.1           Argentina In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product and Services (US$ Mn)

11.1.3.1.2           Argentina In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.3.1.3           Argentina In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.3.1.4           Argentina In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

11.1.4        Rest of South and Central America

11.1.4.1          Rest of South and Central America In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.4.1.1           Rest of South and Central America In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product and Services (US$ Mn)

11.1.4.1.2           Rest of South and Central America In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.4.1.3           Rest of South and Central America In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.4.1.4           Rest of South and Central America In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

12.        Impact Of COVID-19 Pandemic on South and Central America In-Vitro Diagnostics Market

12.1        South and Central America: Impact Assessment of COVID-19 Pandemic

13.        Industry Landscape

13.1        Overview

13.2        Organic Developments Done by The Companies in The Market

13.3        Inorganic Developments Done by The Companies in The Market

14.        COMPANY PROFILES

14.1        Abbott

14.1.1        Key Facts

14.1.2        Business Description

14.1.3        Products and Services

14.1.4        Financial Overview

14.1.5        SWOT Analysis

14.1.6        Key Developments

14.2        F. HOFFMANN-LA ROCHE LTD.

14.2.1        Key Facts

14.2.2        Business Description

14.2.3        Products and Services

14.2.4        Financial Overview

14.2.5        SWOT Analysis

14.2.6        Key Developments

14.3        Danaher

14.3.1        Key Facts

14.3.2        Business Description

14.3.3        Products and Services

14.3.4        Financial Overview

14.3.5        SWOT Analysis

14.3.6        Key Developments

14.4        Siemens AG

14.4.1        Key Facts

14.4.2        Business Description

14.4.3        Products and Services

14.4.4        Financial Overview

14.4.5        SWOT Analysis

14.4.6        Key Developments

14.5        Sysmex Corporation

14.5.1        Key Facts

14.5.2        Business Description

14.5.3        Products and Services

14.5.4        Financial Overview

14.5.5        SWOT Analysis

14.5.6        Key Developments

14.6        THERMO FISHER SCIENTIFIC INC.

14.6.1        Key Facts

14.6.2        Business Description

14.6.3        Products and Services

14.6.4        Financial Overview

14.6.5        SWOT Analysis

14.6.6        Key Developments

14.7        BD

14.7.1        Key Facts

14.7.2        Business Description

14.7.3        Products and Services

14.7.4        Financial Overview

14.7.5        SWOT Analysis

14.7.6        Key Developments

14.8        bioMerieux SA

14.8.1        Key Facts

14.8.2        Business Description

14.8.3        Products and Services

14.8.4        Financial Overview

14.8.5        SWOT Analysis

14.8.6        Key Developments

14.9        BIO-RAD LABORATORIES INC.

14.9.1        Key Facts

14.9.2        Business Description

14.9.3        Products and Services

14.9.4        Financial Overview

14.9.5        SWOT Analysis

14.9.6        Key Developments

14.10     QIAGEN

14.10.1      Key Facts

14.10.2      Business Description

14.10.3      Products and Services

14.10.4      Financial Overview

14.10.5      SWOT Analysis

14.10.6      Key Developments

15.        Appendix

15.1        About the Insight Partners

15.2        Glossary of Terms

 


 

LIST OF TABLES

Table 1.              Key launches 2016: By Roche

Table 2.              Brazil In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product and Services (US$ Mn)

Table 3.              Brazil In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 4.              Brazil In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 5.              Brazil In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 6.              Argentina In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product and Services (US$ Mn)

Table 7.              Argentina In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 8.              Argentina In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 9.              Argentina In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 10.            Rest of South and Central America In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product and Services (US$ Mn)

Table 11.            Rest of South and Central America In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 12.            Rest of South and Central America In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 13.            Rest of South and Central America In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 14.            Organic Developments Done by The Companies

Table 15.            Inorganic Developments Done by The Companies

Table 16.            Glossary of Terms, In-Vitro Diagnostics Market

 


 

LIST OF FIGURES

Figure 1.            In-Vitro Diagnostics Market Segmentation

Figure 2.            South and Central America In-Vitro Diagnostics Market Overview

Figure 3.            Reagents and Kits Segment Held Largest Share of Product and Services in In-Vitro Diagnostics Market

Figure 4.            Infectious Diseases Segment Held Largest Share of Application in In-Vitro Diagnostics Market

Figure 5.            Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.            In-Vitro Diagnostics Market - South and Central America PEST Analysis

Figure 7.            In-Vitro Diagnostics Market Impact Analysis of Driver and Restraints

Figure 8.            South and Central America In-Vitro Diagnostics Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.            In-Vitro Diagnostics, by Product and Services, 2019 & 2027 (% Share)

Figure 10.          Reagents & Kits Market Revenue and Forecast to 2027 (US$ Mn)

Figure 11.          Instruments Market Revenue and Forecast to 2027 (US$ Mn)

Figure 12.          Software & Services Market Revenue and Forecast to 2027 (US$ Mn)

Figure 13.          In-Vitro Diagnostics Market, By Technology, 2019 & 2027 (% Share)

Figure 14.          Immunoassay/Immunochemistry Market Revenue And Forecast To 2027 (US$ Mn)

Figure 15.          Clinical Chemistry Market Revenue And Forecast To 2027 (US$ Mn)

Figure 16.          Molecular Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 17.          Microbiology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 18.          Blood Glucose Self-Monitoring Market Revenue And Forecast To 2027 (US$ Mn)

Figure 19.          Coagulation and Hemostasis Market Revenue And Forecast To 2027 (US$ Mn)

Figure 20.          Hematology Market Revenue and Forecast to 2027 (US$ Mn)

Figure 21.          Urinalysis Market Revenue And Forecast To 2027 (US$ Mn)

Figure 22.          Others Market Revenue And Forecast To 2027 (US$ Mn)

Figure 23.          In-Vitro Diagnostics Market, By Application, 2019 & 2027 (% Share)

Figure 24.          Infectious Diseases Market Revenue And Forecast To 2027 (US$ Mn)

Figure 25.          Diabetes Market Revenue And Forecast To 2027 (US$ Mn)

Figure 26.          Most Prevalent Forms of Cancers Globally, 2018

Figure 27.          Oncology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 28.          Cardiology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 29.          Autoimmune Disease Market Revenue And Forecast To 2027 (US$ Mn)

Figure 30.          Nephrology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 31.          Others Market Revenue And Forecast To 2027 (US$ Mn)

Figure 32.          In-Vitro Diagnostics Market Share by End User 2019 & 2027 (%)

Figure 33.          Hospitals Market Revenue And Forecast To 2027 (US$ Mn)

Figure 34.          Laboratories Market Revenue And Forecast To 2027 (US$ Mn)

Figure 35.          Homecare Market Revenue And Forecast To 2027 (US$ Mn)

Figure 36.          Others Market Revenue and Forecast to 2027 (US$ Mn)

Figure 37.          South and Central America In-Vitro Diagnostics Market Revenue, By Country, 2019 (US$ Mn)

Figure 38.          South and Central America In-Vitro Diagnostics Market Revenue and Forecast to 2027, By Country (%)

Figure 39.          Brazil In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 40.          Argentina In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 41.          Rest of South and Central America In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 42.          Impact of COVID-19 Pandemic in South and Central America Country Markets

Figure 43.          Growth Strategies Done by the Companies in the Market, (%)

 

 

  1. F. HOFFMANN-LA ROCHE LTD.
  2. DANAHER
  3. ABBOTT
  4. SIEMENS AG
  5. SYSMEX CORPORATION
  6. THERMO FISHER SCIENTIFIC, INC.
  7. BD
  8. BIOMERIEUX SA
  9. BIO-RAD LABORATORIES, INC.
  10. QIAGEN
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America In-vitro diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South and Central America In-vitro diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South and Central America market trends and outlook coupled with the factors driving the in-vitro diagnostics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
TIPRE00022126
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing